Cerebral sporotrichosis
ICD-10 B42.81 is a billable code used to indicate a diagnosis of cerebral sporotrichosis.
Cerebral sporotrichosis is a rare form of fungal infection caused by the dimorphic fungus Sporothrix schenckii. This organism is typically found in soil, decaying vegetation, and on the skin of infected animals. Cerebral sporotrichosis occurs when the fungus disseminates to the central nervous system, often following a primary cutaneous infection or through direct inoculation. Patients may present with neurological symptoms such as headaches, seizures, altered mental status, and focal neurological deficits. Diagnosis is confirmed through culture of the organism from cerebrospinal fluid (CSF) or brain tissue, as well as serological tests. Treatment typically involves antifungal therapy, with itraconazole being the first-line agent. In severe cases, especially in immunocompromised patients, amphotericin B may be required. The prognosis varies depending on the patient's immune status and the timeliness of treatment initiation. Immunocompromised individuals, such as those with HIV/AIDS or undergoing immunosuppressive therapy, are at a higher risk for disseminated infections, including cerebral sporotrichosis, necessitating vigilant monitoring and prompt intervention.
Detailed clinical notes on the patient's history, presenting symptoms, and treatment response.
Patients presenting with neurological symptoms and a history of cutaneous sporotrichosis.
Ensure thorough documentation of the patient's immune status and any underlying conditions.
Neurological examination findings, imaging results, and treatment plans.
Patients with seizures or altered mental status suspected of having cerebral infections.
Document any neurological deficits and their progression over time.
Used when culturing CSF or tissue for diagnosis.
Document the source of the culture and the clinical indication.
Infectious disease specialists should ensure proper specimen handling.
Common symptoms include headaches, seizures, altered mental status, and focal neurological deficits, often following a primary cutaneous infection.
